Epilepsy affects approximately 600,000 people in the United Kingdom, according to the Epilepsy Society. Anti-epileptic drugs (AEDs) — now increasingly referred to as anti-seizure medications (ASMs) — are among the most clinically sensitive medicines dispensed in community pharmacy. Generic substitution, missed doses and drug interactions can each trigger breakthrough seizures, making the pharmacist's role at the dispensing counter unusually important.
Why pharmacy counselling matters for epilepsy
NICE guideline CG137 on the epilepsies recommends that patients receive structured information about their medication at every stage of treatment. In practice, many patients collect repeat prescriptions for years without a substantive conversation about their medicine. The New Medicine Service (NMS) offers a framework for structured follow-up when a patient starts a new AED, and the Structured Medication Review (SMR) is an opportunity to revisit long-term therapy.
MHRA safety guidance is particularly relevant for AEDs. The 2024 updated valproate Pregnancy Prevention Programme requires pharmacists to check that female patients of childbearing potential have an Annual Risk Acknowledgement Form in place before dispensing. Failure to verify this is a regulatory and clinical risk.
The medicines: what pharmacists dispense most
First-line AEDs
| Medicine | Common indications | Key counselling points |
|---|---|---|
| Sodium valproate | Generalised epilepsy, absence seizures | Teratogenic — Pregnancy Prevention Programme mandatory for women of childbearing potential. Weight gain, tremor, hair thinning common |
| Lamotrigine | Focal and generalised epilepsy | Slow titration essential to reduce rash risk (Stevens-Johnson syndrome). Dose adjustment needed with combined oral contraceptive |
| Levetiracetam | Focal and generalised epilepsy | Psychiatric side effects (irritability, depression) — warn patients and carers. No significant drug interactions |
| Carbamazepine | Focal epilepsy | Hepatic enzyme inducer — significant interactions with oral contraceptives, warfarin, other AEDs. Check for HLA-B*1502 in patients of Han Chinese or Thai origin before starting |
Second-line and adjunctive AEDs
| Medicine | Key counselling points |
|---|---|
| Topiramate | Teratogenic (MHRA 2024 restrictions for women of childbearing potential). Cognitive dulling, weight loss, kidney stones |
| Zonisamide | Weight loss, kidney stones, reduced sweating — advise hydration |
| Clobazam | Benzodiazepine — tolerance and dependence risk with long-term use |
| Pregabalin | Schedule 3 controlled drug. Dizziness, weight gain. Increasingly prescribed but abuse potential noted |
Pregnancy and epilepsy: the pharmacist's gatekeeping role
Valproate is the most effective AED for generalised epilepsy but carries up to a 40% risk of neurodevelopmental disorders in exposed pregnancies, according to MHRA safety data. Since 2018, the Pregnancy Prevention Programme has required:
- Annual specialist review with signed Risk Acknowledgement Form
- Effective contraception in place
- Pharmacist verification at each dispensing
Lamotrigine and levetiracetam are generally considered lower-risk alternatives in pregnancy, though NICE recommends specialist-led switching well before conception. Pharmacists should refer any woman of childbearing potential on valproate who does not have documentation of the annual review.
Carbamazepine carries a lower but still elevated risk of neural tube defects. Folic acid 5mg daily (not the standard 400mcg) is recommended for all women taking AEDs who may become pregnant, according to NICE CG137.
Generic substitution: why it matters more for AEDs
MHRA guidance classifies AEDs into three categories for generic substitution:
- Category 1 (maintain same manufacturer): phenytoin, carbamazepine, phenobarbital, primidone
- Category 2 (switching may be acceptable with monitoring): valproate, lamotrigine, perampanel, retigabine, rufinamide, clobazam, clonazepam, oxcarbazepine, eslicarbazepine, zonisamide, topiramate
- Category 3 (usually safe to switch): levetiracetam, lacosamide, tiagabine, gabapentin, pregabalin
For Category 1 medicines, pharmacists should maintain the same manufacturer wherever possible. Switching brands of phenytoin, for example, can cause clinically significant changes in serum levels due to the narrow therapeutic index.
When to refer
Community pharmacists should refer patients to their GP or epilepsy specialist when:
- A patient reports increased seizure frequency or new seizure types
- A patient on valproate is planning pregnancy or discovers they are pregnant
- Signs of medication toxicity appear (nystagmus with phenytoin, tremor with valproate, rash with lamotrigine)
- A patient requests to stop or reduce their AED — abrupt withdrawal can trigger status epilepticus
- Drug interactions are identified (particularly with enzyme-inducing AEDs and oral contraceptives, anticoagulants or immunosuppressants)
Purple Day and pharmacy awareness
Purple Day (26 March) is an international epilepsy awareness initiative. Community pharmacies can support awareness by displaying information about seizure first aid — the key messages being: cushion the head, do not restrain, time the seizure, call 999 if it lasts longer than five minutes. Simple counter-top materials from Epilepsy Action or the Epilepsy Society are available free of charge.
The opportunity for pharmacy
According to PharmSee's tracker of 1,715 active pharmacy vacancies across 11 sources (data as of April 2026), community pharmacists are the most accessible healthcare professional in most neighbourhoods. For epilepsy patients, that accessibility translates into a unique opportunity: the pharmacist may see a patient collecting their AED monthly when their neurologist sees them annually. Structured Medication Reviews, NMS consultations and proactive pregnancy counselling can all improve outcomes.
For pharmacists looking to explore clinical roles in neurology, PharmSee's job search tracks NHS specialist pharmacist vacancies across England, while the salary guide provides context on NHS Band 7–8a neurology pharmacist pay.
Data sources: NICE CG137 (The Epilepsies), MHRA AED category guidance, Epilepsy Society prevalence estimates, PharmSee vacancy tracker (April 2026, 1,715 active roles across 11 sources).